What one share of NRx Pharmaceuticals holds
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx”, the “Company”, “we”, “us” or “our”) is a clinical-stage bio-pharmaceutical company which develops and will distribute, through its wholly-owned operating subsidiary, NeuroRx, Inc., (NeuroRx), novel therapeutics for the treatment of central nervous system disorders including suicidal depression, chronic pain, post-traumatic stress disorder (PTSD) and schizophrenia.
NRx Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.11 |
|---|---|
| Profit | −$0.78 |
| Cash and investments | $0.62 |
| Debt | $0.00 |
| Book value | −$0.00 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | — | −$2.86 | — | — | — | $18.35 |
| 2019 | — | −$1.10 | — | — | — | −$17.03 |
| 2020 | — | −$15.11 | $0.00 | −$0.66 | — | −$10.19 |
| 2021 | — | −$19.84 | $0.00 | −$8.04 | — | $3.54 |
| 2022 | — | −$6.04 | $0.00 | −$6.05 | — | $1.12 |
| 2023 | $0.00 | −$3.98 | $0.00 | −$2.86 | — | −$1.40 |
| 2024 | $0.00 | −$2.36 | $0.00 | −$1.00 | — | −$1.59 |
| 2025 | $0.06 | −$1.34 | — | — | — | −$0.50 |
Common questions about NRx Pharmaceuticals
How much does one share of NRx Pharmaceuticals earn?
Over the last 12 months, NRx Pharmaceuticals lost $0.78 for each share on $0.11 of sales.
Does NRx Pharmaceuticals pay a dividend?
NRx Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is NRx Pharmaceuticals’s book value per share?
NRx Pharmaceuticals’s book value is negative (−$0.00 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of NRx Pharmaceuticals have?
Each share of NRx Pharmaceuticals has $0.62 of cash and investments and $0.00 of debt, as of June 30, 2026.
Has NRx Pharmaceuticals bought back shares?
NRx Pharmaceuticals’s share count rose about 8086% from 2018 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.